Abstract
Seizures are an infrequent complication of drug administration. For example, medication-associated seizures were reported in 0.08% of patients in the Boston Collaborative Surveillance Program in which 32,812 consecutive patients were monitored for medication side effects (1). Nevertheless, patients with spontaneous or recurrent seizures are encountered regularly by clinicians, and these individuals are often taking medications that have been reported to cause seizures. The Physicians’ Desk Reference lists seizures as a potential adverse effect for approx. 250 preparations. Establishing a causal relationship between seizures and a given medication is often difficult, however.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Porter J, Jick H. Drug-induced anaphylaxis, convulsions, deafness, and extrapyramidal symptoms. Lancet 1977; 1: 587–588.
Hauser WA, Hesdorffer DC. Epilepsy: Frequency, Causes and Consequences. New York: Demos, 1990: 11.
Rosenstein DL, Nelson JC, Jacobs SC. Seizures associated with antidepressants: a review. J Clin Psychiatry 1993; 54: 289–299.
Messing RO, Closson RG, Simon RP. Drug-induced seizures: a 10-year experience. Neurology 1984; 34: 1582–1586.
Garcia PA, Alldredge BK. Drug-induced seizures. Neurol Clin 1994; 12: 85–99.
Wallace KL. Antibiotic-induced convulsions. Crit Care Clin 1997; 13: 741–762.
Fujimoto M, Munakata M, Akaike N. Dual mechanisms of GABAA response inhibition by beta-lactam antibiotics in the pyramidal neurones of the rat cerebral cortex. Br J Pharmacol 1995; 116: 3014–3020.
Paronis CA, Bergman J. Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys. J Pharmacol Exp Ther 1999; 290: 1222–1229.
Jacobson MA. Review of the toxicities of foscarnet. J Acquir Immune Defic Syndr 1992; 5: S11 - S17.
Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W. Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine. JAMA 1990; 263: 1641–1645.
Currie TT, Hayward NJ, Westlake G, Williams J. Epilepsy in cardiopulmonary bypass patients receiving large intravenous doses of penicillin. J Thorac Cardiovasc Surg 1971; 62: 1–6.
Dobell AR, Wyant JD, Seamans KB, Gloor P. Penicillin epilepsy. Studies on the blood-brain barrier during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1966; 52: 469–475.
Seamans KB, Gloor P, Dobell RAR, Wyant JD. Penicillin-induced seizures during cardiopulmonary bypass. A clinical and electroencephalographic study. N Engl J Med 1968; 278: 861–868.
Gutnick MJ, Van Duijn H, Citri N. Relative convulsant potencies of structural analogues of penicillin. Brain Res 1976; 114: 139–143.
Walker AE. Convulsive factor in commercial penicillin Arch Surg 1945; 50: 69–73.
Nicholls PJ. Neurotoxicity of penicillin. JAntimicrob Chemother 1980; 6: 161–165.
Fossieck B Jr, Parker RH. Neurotoxicity during intravenous infusion of penicillin. A review. J Clin Pharmacol 1974; 14: 504–512.
Edwards WM, Kellsey DC. Toxicity of intrathecal penicillin. US Armed Forces Med J 1950; 1: 806–811.
Schliamser SE, Cars O, Norrby SR. Neurotoxicity of beta-lactam antibiotics: predisposing factors and pathogenesis. JAntimicrob Chemother 1991; 27: 405–425.
Barrons RW, Murray KM, Richey RM. Populations at risk for penicillin-induced seizures. Ann Pharmacother 1992; 26: 26–29.
Day IP, Goudie J, Nishiki K, Williams PD. Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem/cilastatin and meropenem. Toxicol Lett 1995; 76: 239–243.
de Sarro A, Imperatore C, Mastroeni P, de Sarro G. Comparative convulsant potencies of two carbapenem derivatives in C57 and DBA/2 mice. J Pharm Pharmacol 1995; 47: 292–296.
Tsuji A, Sato H, Kume Y, etal Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes. Antimicrob Agents Chemother 1988; 32: 190–194.
Akahane K, Sekiguchi M, Une T, Osada Y. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites. Antimicrob Agents Chemother 1989; 33: 1704–1708.
Arcieri GM, Becker N, Esposito B, et al. Safety of intravenous ciprofloxacin. A review. Am J Med 1989; 87: 92S - 97S.
Polk RE. Drug-drug interactions with ciprofloxacin and other fluoroquinolones. Am J Med 1989; 87: 76S - 81S.
Segev S, Rehavi M, Rubinstein E. Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor. Antimicrob Agents Chemother 1988; 32: 1624–1626.
Halliwell RF, Davey PG, Lambert JJ. Antagonism of GABAA receptors by 4quinolones. J Antimicrob Chemother 1993; 31: 457–462.
Sievers ML, Cynamon MH, Bittker TE. Intentional isoniazid overdosage among southwestern American Indians. Am J Psychiatry 1975; 132: 662–665.
Brown CV. Acute isoniazid poisoning. Am Rev Respir Dis 1972; 105: 206–216.
Gilhotra R, Malik SK, Singh S, Sharma BK. Acute isoniazid toxicity-report of 2 cases and review of literature. Int J Clin Pharmacol Ther Toxicol 1987; 25: 259–261.
Sievers ML, Herrier RN. Treatment of acute isoniazid toxicity. Am J Hosp Pharm 1975; 32: 202–206.
Miller J, Robinson A, Percy AK. Acute isoniazid poisoning in childhood. Am J Dis Child 1980; 134: 290–292.
Wood ER. Isoniazid toxicity. Pyridoxine controlled seizures in a dialysis patient. J Kans Med Soc 1981; 82: 551–552.
Wason S, Lacouture PG, Lovejoy FH Jr. Single high-dose pyridoxine treatment for isoniazid overdose. JAMA 1981; 246: 1102–1104.
Santucci KA, Shah BR, Linakis JG. Acute isoniazid exposures and antidote availability. Pediatr Emerg Care 1999; 15: 99–101.
Terman DS, Teitelbaum DT. Isoniazid self-poisoning. Neurology 1970; 20: 299–304.
Balfour HH. Acyclovir. In: Peterson PK, Verhoef J (eds.), The Antimicrobial Agents Annual, 3rd ed. Amsterdam- Elsevier Science, 1988: 349.
American Academy of Pediatrics Committee on Infectious Diseases: The status of acellular pertussis vaccines: current perspective. Pediatrics 1991; 88: 401–405.
Blumenreich MS, Woodcock TM, Sherrill EJ, et al. A phase I trial of chlorambucil administered in short pulses in patients with advanced malignancies. Cancer Invest 1988; 6: 371–375.
Vassal G, Deroussent A, Hartmann O, et al. Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study. Cancer Res 1990; 50: 6203–6207.
Wijdicks EF, Plevak DJ, Wiesner RH, Steers JL. Causes and outcome of seizures in liver transplant recipients. Neurology 1996; 47: 1523–1525.
Thistlethwaite JR Jr, Stuart JK, Mayes JT, et al. Complications and monitoring of OKT3 therapy. Am J Kidney Dis 1988; 11: 112–119.
Shakil AO, Di Bisceglie AM, Hoofnagle JH. Seizures during alpha interferon therapy (see comments). J Hepatol 1996; 24: 48–51.
Munschauer FE III, Kinkel RP. Managing side effects of interferon-beta in patients with relapsing-remitting multiple sclerosis. Clin Ther 1997; 19: 883–893.
Physicians Desk Reference. Montvale: Medical Economics Company, 1999.
Cohen A. Accidental overdose of tocainide successfully treated. Angiology 1987; 38: 614.
Jequier P, Jones R, Mackintosh A. Letter: Fatal mexiletine overdose. Lancet 1976; 1: 429.
Douglas EF, White PT, Nelson JW. Three per second spike-wave in digitalis toxicity. Report of a case. Arch Neurol 1971; 25: 373–375.
Johnson N, Martin ND, Strathdee G. Epileptiform convulsion with intravenous disopyramide [letter]. Lancet 1978; 2: 848.
Olson KR, Benowitz NL, Woo OF, Pond SM. Theophylline overdose: acute single ingestion versus chronic repeated overmedication. Am J Emerg Med 1985; 3: 386–394.
Aitken ML, Martin TR. Life-threatening theophylline toxicity is not predictable by serum levels. Chest 1987; 91: 10–14.
Alldredge BK, Lowenstein DH, Simon RP. Seizures associated with recreational drug abuse. Neurology 1989; 39: 1037–1039.
Osuide G, Wambebe C, Ngur D. Studies on the pharmacology of d-amphetamine on maximal electroconvulsive seizure in young chicks. Psychopharmacology 1983; 81: 119–121.
Lake CR, Gallant S, Masson E, Miller R. Adverse drug effects attributed to phenylpropanolamine• a review of 142 case reports. Am J Med 1990; 89: 195–208.
Ojemann LM, Baugh-Bookman C, Dudley DL. Effect of psychotropic medications on seizure control in patients with epilepsy. Neurology 1987; 37: 1525–1527.
Alldredge BK. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology 1999; 53: S68 - S75.
Starkey IR, Lawson AA. Poisoning with tricyclic and related antidepressants-a ten-year review. Q J Med 1980; 49: 33–49.
Biggs JT, Spiker DG, Petit JM, Ziegler VE. Tricyclic antidepressant overdose: incidence of symptoms. JAMA 1977; 238: 135–138.
Ellison DW, Pentel PR. Clinical features and consequences of seizures due to cyclic antidepressant overdose. Am J Emerg Med 1989; 7: 5–10.
Boehnert MT, Lovejoy FH Jr. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med 1985; 313: 47479.
Wedin GP, Oderda GM, Klein-Schwartz W, Gorman RL. Relative toxicity of cyclic antidepressants. Ann Emerg Med 1986; 15: 797–804.
Phillips S, Brent J, Kulig K, Heiligenstein J, Birkett M. Fluoxetine versus tricyclic antidepressants: a prospective multicenter study of antidepressant drug overdoses. The Antidepressant Study Group. J Emerg Med 1997; 15: 439–445.
Favale E, Rubino V, Mainardi P, Lunardi G, Albano C. Anticonvulsant effect of fluoxetine in humans. Neurology 1995; 45: 1926–1927.
Davidson J. Seizures and bupropion: a review. J Clin Psychiatry 1989; 50: 256–261.
Skowron DM, Stimmel GL. Antidepressants and the risk of seizures. Pharmacotherapy 1992; 12: 18–22.
Preskorn SH, Fast GA. Tricyclic antidepressant-induced seizures and plasma drug concentration. J Clin Psychiatry 1992; 53: 160–162.
Cann HM, Verhulst HL. Accidental ingestion and overdosage involving psychopharmacologic drugs. N Engl J Med 1960; 263: 719–724.
Acri AA, Henretig FM. Effects of risperidone in overdose. Am J Emerg Med 1998; 16: 498–501.
Remick RA, Fine SH. Antipsychotic drugs and seizures. J Clin Psychiatry 1979; 40: 78–80.
Devinsky O, Honigfeld G, Patin J. Clozapine-related seizures. Neurology 1991; 41: 369–371.
Simard M, Gumbiner B, Lee A, Lewis H, Norman D. Lithium carbonate intoxication. A case report and review of the literature. Arch Intern Med 1989; 149: 36–46.
Massey EW, Folger WN. Seizures activated by therapeutic levels of lithium carbonate. South Med J 1984; 77: 1173–1175.
Helmchen H, Kanowski S. EEG changes under Lithium (Li) treatment. Electroencephalogr Clin Neurophysiol 1971; 30: 269.
Elger CE, Bauer J, Scherrmann J, Widman G. Aggravation of focal epileptic seizures by antiepileptic drugs. Epilepsia 1998; 39: S15 - S18.
Guerrini R, Belmonte A, Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia 1998; 39: S2 - S10.
Berkovic SF. Aggravation of generalized epilepsies. Epilepsia 1998; 39: S11 - S14.
Buckman K, Claiborne K, de Guzman M, Walberg CB, Haywood LJ. Lidocaine efficacy and toxicity assessed by a new, rapid method. Clin Pharmacol Ther 1980; 28: 177–181.
Pelter MA, Vollmer TA, Blum RL. Seizure-like reaction associated with subcutaneous lidocaine injection [letter]. Clin Pharm 1989; 8: 767–768.
Sundaram MB. Seizures after intraurethral instillation of lidocaine. CMAJ. 1987; 137: 219–220.
Pascual J, Sedano MJ, Polo JM, Berciano J. Intravenous lidocaine for status epilepticus. Epilepsia 1988; 29: 584–589.
Naguib M, Magboul MM, Samarkandi AH, Attia M. Adverse effects and drug interactions associated with local and regional anaesthesia. Drug Saf 1998; 18: 221–250.
Quail AW. Modern inhalational anaesthetic agents. A review of halothane, isoflurane and enflurane. Med J Aust 1989; 150: 95–102.
Ashton D. Diazepam, pentobarbital and D-etomidate produced increases in bicuculline seizure threshold; selective antagonism by RO15–1788, picrotoxin and (+/—)-DMBB. Eur J Pharmacol 1983; 94: 319–325.
Gancher S, Laxer KD, Krieger W. Activation of epileptogenic activity by etomidate. Anesthesiology 1984; 61: 616–618.
Kaiko RF, Foley KM, Grabinski PY, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983; 13: 180–185.
Mather LE, Tucker GT. Systemic availability of orally administered meperidine. Clin Pharmacol Ther 1976; 20: 535–540.
Tobias JD. Seizure after overdose of tramadol. South Med J 1997; 90: 826–827.
Kahn LH, Alderfer RJ, Graham DJ. Seizures reported with tramadol [letter]. JAMA 1997; 278: 1661.
Spiller HA, Gorman SE, Villalobos D, et al. Prospective multicenter evaluation of tramadol exposure. J Toxicol Clin Toxicol 1997; 35: 361–364.
Spivey WH. Flumazenil and seizures: analysis of 43 cases. Clin Ther 1992; 14: 292–305.
Nelson M, Bartlett RJ, Lamb JT. Seizures after intravenous contrast media for cranial computed tomography. J Neurol Neurosurg Psychiatry 1989; 52: 1170–1175.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Garcia, P.A., Alldredge, B.K. (2002). Medication-Associated Seizures. In: Delanty, N. (eds) Seizures. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-094-0_9
Download citation
DOI: https://doi.org/10.1007/978-1-59259-094-0_9
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-207-0
Online ISBN: 978-1-59259-094-0
eBook Packages: Springer Book Archive